Joint Formulary & PAD

Prednisolone - Inflammatory disorders

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
 

Status 2

Green (see narrative)
Formulations :
  • Soluble tablets
Associated Icons :
Restrictions / Comments :
Important

Not a preferred formulation. Ordinary tablets can be dispersed in water. Only use a dispersible tablet where a patient is unable to disperse an ordinary tablet.

 

Status 3

Green (see narrative)
Formulations :
  • Oral solution
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important

Reserved for patients with fine bore NG tube or patients who require doses of less than 5mg which could otherwise be obtained from a dispersing an ordinary 5mg tablet.
An option in paeds who cannot tolerate the taste of dispersible tablets.

 

Status 4

Non Formulary
Formulations :
  • Enteric coated tablets
Associated Icons :
BNF SPC
NFD1
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Prednisolone
Indication :
Inflammatory disorders
Group Name :
Keywords :
oral corticosteroids, oral steroids, glucocorticoid therapy, systemic corticosteroids
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
4

Other Indications

Below are listed other indications that Prednisolone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Inflammatory disorders.

Committee Recommendations (0)

  • No records returned.